Product Images Quetiapine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Quetiapine NDC 29300-308 by Unichem Pharmaceuticals (usa), Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Image - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 01

Image - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 01

Image - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 02

Image - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 02

Image - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 03

Image - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 03

Image - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 04

Image - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 04

Image - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 05

Image - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 05

Quetiapine Exended-Release Tablets USP, 50 mg - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 06

Quetiapine Exended-Release Tablets USP, 50 mg - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 06

This is the label for Quetiapine Extended Release tablets which comes in a pack of 60 tablets. The medication is to be taken once daily and should be stored between 20-25°C. The manufacturer is Unichem Laboratories Ltd. The label includes a warning to keep the medication out of reach of children and a reference to a pharmacist for further information. The is shaky and therefore some parts of text are unclear.*

Quetiapine Extended-Release Tablets USP, 150 mg - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 07

Quetiapine Extended-Release Tablets USP, 150 mg - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 07

This is a drug container label for Quetiapine Fumarate tablets, an extended-release drug manufactured by UNICHE Laboratories LTD and distributed by UNICHEM Pharmaceuticals (USA), INC. The label shows the drug's National Drug Code (NDC), its composition, warning not to split, crush, or chew the tablets, and to store them in a tight, light-resistant container in a cool and dry place. The label also provides information on proper dispensing and cautions on keeping the medication out of children's reach. The label includes manufacturing and expiry dates and names and addresses of the manufacturers and distributors.*

Quetiapine Extended-Release Tablets USP, 200 mg - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 08

Quetiapine Extended-Release Tablets USP, 200 mg - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 08

This is a description of a medication with the NDC 29300-310-16. It is an extended-release tablet containing 230.26mg of Quetiapine. It is a controlled substance that should not be split, crushed or chewed, and should be taken once daily. It is manufactured by UNICHE LABORATORIES LTD for UNICHEM PHARMACEUTICALS (USA), INC. It should be stored in a tight container at 20°C to 25°C with excursions permitted between 15° to 30°C. The accompanying medication guide should be dispensed to each patient, and the medication should be kept out of reach of children.*

Quetiapine Extended-Release Tablets, USP, 300 mg - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 09

Quetiapine Extended-Release Tablets, USP, 300 mg - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 09

This text describes a medication called Quetiapine Extended-Release Tablets that should be taken once daily and stored in a tight, light-resistant container at a temperature between 20°C to 25°C (68°F to 77°F). The medication should not be crushed, split, or chewed. The accompanying prescribing information and medication guide should be given to each patient by the pharmacist. The medication is manufactured by Unichem Pharmaceuticals (USA) Inc. and the tablets are dispensed in a container as defined in the USP. The text also includes warnings to keep this medication out of reach of children.*

Quetiapine Extended-Release tablets USP, 400 mg - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 10

Quetiapine Extended-Release tablets USP, 400 mg - 3ec5c4ad 8a55 4091 ada4 4e009332a5ec 10

This is a medication description for Quetiapine Extended-Release Tablets, USP. Each extended-release tablet contains 460.52mg of Quetiapine Fumarate USP equivalent to 10400 mg of Quetiapine. The tablets should be swallowed whole and not split, crushed, or chewed. The recommended dosage is once daily as per the accompanying prescribing information. The medication should be stored in a tight, light-resistant container defined in the USP and kept at a controlled room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15° to 30°C (S to 86°F). The medication should be kept away from children. The medication comes in a container of 60 tablets and includes an accompanying medication guide for each patient. Manufactured by UniChem Laboratories LTD in India and manufactured for UniChem Pharmaceuticals (USA), Inc. in East Brunswick, NJ, USA.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.